Personal Information
Organization / Workplace
New York, NY United States
Occupation
Chairman and Chief Executive Officer
Industry
Finance / Banking / Insurance
Website
lindsayrosenwald.com/
About
Throughout his career, Dr. Lindsay Rosenwald has championed numerous biotechnology entrepreneurs and researchers. Currently a co-founder and partner of an asset management firm, the industry veteran has a track record of success in bringing medical treatment development projects to fruition. He has played an integral role in securing approval from federal and international authorities for more than one dozen devices and medications. Leveraging two decades of experience in the biotech sector, Dr. Lindsay Rosenwald continues to identify up-and-coming companies as the industry increasingly expands.
Tags
lindsay rosenwald
zytiga
health
research
opus point partners
biotechnology
cancer
dr. lindsay rosenwald
pharmaceutical
drug discovery
medicine
pharmaceuticals
abiraterone acetate
cancer-fighting
pharmaceutical drug
combination therapy
cancer research
the board of visitors at temple university's schoo
prostate cancer treatment drug may have wider uses
temple director
cancer work
recognition
amgen
cougar biotechnology
cancer diagnosis
cancer staging
oncology
biopharmaceuticals
disease
schizophrenia
li
temple university school of medicine board of visi
milnacipran
fibromyalgia
influenza
dr. lindsay a. rosenwald
new drug development
clinical trials
fda approval
validation
target identification
21st century
veterinary medicine
pets
johnson & johnson
acquisition
biotechnology company
prostate cancer patients
benefits
men
blood test could aid in early breast cancer diagno
genetic contributors
esophageal cancer
protein
lung cancer
cancer treatment drug
some information on acute promyelocytic leukemia
joint membranes
risk factors of rheumatoid arthritis
family history of rheumatoid arthritis
investment partnership
joint falls out of alignment
biotech
women greater risk
immune system
behavioral treatments
overactive bladder
treatment
chemotherapy
prostate cancer
active surveillance
prostate cancer treatment
See more
Presentations
(12)Personal Information
Organization / Workplace
New York, NY United States
Occupation
Chairman and Chief Executive Officer
Industry
Finance / Banking / Insurance
Website
lindsayrosenwald.com/
About
Throughout his career, Dr. Lindsay Rosenwald has championed numerous biotechnology entrepreneurs and researchers. Currently a co-founder and partner of an asset management firm, the industry veteran has a track record of success in bringing medical treatment development projects to fruition. He has played an integral role in securing approval from federal and international authorities for more than one dozen devices and medications. Leveraging two decades of experience in the biotech sector, Dr. Lindsay Rosenwald continues to identify up-and-coming companies as the industry increasingly expands.
Tags
lindsay rosenwald
zytiga
health
research
opus point partners
biotechnology
cancer
dr. lindsay rosenwald
pharmaceutical
drug discovery
medicine
pharmaceuticals
abiraterone acetate
cancer-fighting
pharmaceutical drug
combination therapy
cancer research
the board of visitors at temple university's schoo
prostate cancer treatment drug may have wider uses
temple director
cancer work
recognition
amgen
cougar biotechnology
cancer diagnosis
cancer staging
oncology
biopharmaceuticals
disease
schizophrenia
li
temple university school of medicine board of visi
milnacipran
fibromyalgia
influenza
dr. lindsay a. rosenwald
new drug development
clinical trials
fda approval
validation
target identification
21st century
veterinary medicine
pets
johnson & johnson
acquisition
biotechnology company
prostate cancer patients
benefits
men
blood test could aid in early breast cancer diagno
genetic contributors
esophageal cancer
protein
lung cancer
cancer treatment drug
some information on acute promyelocytic leukemia
joint membranes
risk factors of rheumatoid arthritis
family history of rheumatoid arthritis
investment partnership
joint falls out of alignment
biotech
women greater risk
immune system
behavioral treatments
overactive bladder
treatment
chemotherapy
prostate cancer
active surveillance
prostate cancer treatment
See more